My project integrates in vitro experiments using breast cancer cell lines, where I apply both genetic and pharmacological treatments combining m6A and splicing inhibitors. I use cutting edge techniques like Nanopore Sequencing together with mathematical modelling frameworks developed by the bioinformaticians in the lab to deeply understand the molecular consequences of combined therapies.